Background illustration for clinical trials search

Paid Clinical Trials Missouri

Discover 1,815 paid clinical trials in Missouri. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
FeaturedActive & Responsive

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

for
Overweight, Prediabetic State, Prehypertension,
Location: Boston MA, New Haven CT, Waterbury CT, Hartsdale NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07794579

Phase 3, Recruiting
FeaturedActive & Responsive

Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin

for
Diabetes Mellitus, Type 2, Obesity
Location: East Greenwich RI, Morehead City NC, Hampton VA,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea

for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Hampton VA, New Bern NC,

Sex: All

Age: 18+

Recruiting
Active & Responsive

BioPoly® Partial Resurfacing Knee Implant IDE

for
Knee Pain Chronic, Knee Osteoarthritis, Cartilage Damage,
Location: Fort Wayne IN, Chesterfield MO, Rochester MN,
Sponsor: BioPoly LLC

Sex: All

Age: 30 - 65

Code: NCT06915363

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

for
Preventive Treatment of Migraine
Location: Boca Raton FL, Winter Park FL, Ann Arbor MI,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07729462

Phase 3, Recruiting
Active & Responsive

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia

Sex: All

Age: 18 - 70+

Code: NCT07322003

Phase 3, Recruiting
Active & Responsive

Study of DISC-0974-201 in Participants With IBD and Anemia

for
Inflammatory Bowel Disease (IBD), Anemia,
Location: Providence RI, Miami Lakes FL, Miami FL, Doral FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT07368972

Phase 2, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Miro3D Randomized Controlled Trial (RCT)

for
Wound
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT07347106

Recruiting
Active & Responsive

Neuroimaging of Parkinson's

for
Parkinsons Disease (PD)
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 40+

Code: NCT07024875

Recruiting
Active & Responsive

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

for
Leadless Pacemaker, Bradycardia, AV Block,
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Biotronik, Inc.

Sex: All

Age: 18+

Code: NCT07118358

Recruiting
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New York NY, Belleville NJ, East Brunswick NJ,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase 3, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: Boston MA, New York NY, Philadelphia PA, Durham NC,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting
Active & Responsive

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

for
Diabetes Mellitus, Type 1
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 65

Code: NCT06503809

Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase 2, Phase 3, Recruiting
Active & Responsive

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Brewer ME, Bath ME, Portland ME, Scarborough ME,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting
Active & Responsive

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05136196

Phase 2, Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase 2, Recruiting

Popular cities in Missouri

With its expansive healthcare network and renowned medical research institutions, Missouri is a central hub for a diverse range of clinical trials. Leading organizations such as Washington University School of Medicine in St. Louis, the University of Missouri Health Care, and St. Louis University are at the forefront of groundbreaking studies. These institutions drive innovation in medical research and offer unique opportunities for participants to engage in cutting-edge clinical trials, contributing to advancements in healthcare both locally and nationwide.

Why choose Missouri for clinical trials?

Missouri has a diverse population which ensures a wide variety of participants can take part in clinical trials, enhancing the accuracy, applicability, and validity of clinical research findings. The state is also home to a thriving research environment, with a strong emphasis on medical innovation and cutting-edge studies led by world-class institutions.

By choosing to participate in a clinical trial in Missouri, individuals contribute to critical advancements in medical research while benefiting from a well-established and supportive clinical research infrastructure.

Common conditions studied in Missouri

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Missouri